檢索結果 - Ken Inada
- Showing 1 - 20 results of 37
- Go to Next Page
-
1
-
2
-
3
Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database 由 Kentaro Yamato, Ken Inada, Minori Enomoto, Tatsuro Marumoto, Masahiro Takeshima, Kazuo Mishima
發表在 BMC Psychiatry (2021-01-01)獲取全文
Article -
4
Stigmatized attitudes of medical staff toward people who use drugs and their determinants in Japanese medical facilities specialized in addiction treatment 由 Munenori Katayama, So Fujishiro, Kanna Sugiura, Jun Konishi, Ken Inada, Norihito Shirakawa, Toshihiko Matsumoto
發表在 Neuropsychopharmacology Reports (2023-12-01)獲取全文
Article -
5
Factors associated with death, hospitalization, resignation, and sick leave from work among patients with schizophrenia in Japan: a nested case–control study using a large claims d... 由 Ken Inada, Yoshitaka Saito, Kenji Baba, Daisuke Fukui, Yuriko Masuda, Sachie Inoue, Takahiro Masuda
發表在 BMC Psychiatry (2024-01-01)獲取全文
Article -
6
Greater impact of COVID‐19 on peer‐supported addiction services than government‐owned services for addiction in Japan: A nationwide 3‐year longitudinal cohort study 由 Munenori Katayama, Sou Fujishiro, Kanna Sugiura, Jun Konishi, Ken Inada, Norihito Shirakawa, Toshihiko Matsumoto
發表在 PCN Reports (2024-12-01)獲取全文
Article -
7
-
8
-
9
Comparison of Efficacies of a Blonanserin Transdermal Patch and Blonanserin Oral Formulation for Psychiatric Symptoms in Patients With Schizophrenia Treated With Laxatives Using a... 由 Ken Inada, Hiroyuki Muraoka, Yuji Matsumoto, Daisuke Fukui, Tomomi Watanabe, Yuriko Masuda, Sachie Inoue, Takahiro Masuda
發表在 Neuropsychopharmacology Reports (2025-03-01)獲取全文
Article -
10
Effects of chronic haloperidol treatment on the expression of fear memory and fear memory extinction in the cued fear‐conditioned rats 由 Kosuke Enomoto, Kazuro Shibata, Hiroyuki Muraoka, Masahiko Kawano, Ken Inada, Jun Ishigooka, Katsuji Nishimura, Hidehiro Oshibuchi
發表在 Neuropsychopharmacology Reports (2024-03-01)獲取全文
Article -
11
-
12
Psychometric Properties of the Drug Stigma Scale Among Community Pharmacists Concerning Individuals Who Use Over‐The‐Counter Drugs 由 Munenori Katayama, Takuya Shimane, Norihito Shirakawa, Kanna Sugiura, Ken Inada, Jun Konishi, Yoshihito Sakurai, Keiji Kobara, So Fujishiro, Toshihiko Matsumoto
發表在 Neuropsychopharmacology Reports (2026-03-01)獲取全文
Article -
13
A Longitudinal Study of the Association of Blood Unsaturated Fatty Acids With Posttraumatic Stress Disorder (PTSD) 由 Tomoko Inoue, Shintaro Ogawa, Zui Narita, Masayuki Sekiguchi, Yasushi Asari, Yuichi Kataoka, Jun Hattori, Hiroaki Hori, Yoshiharu Kim, Ken Inada
發表在 Neuropsychopharmacology Reports (2025-03-01)獲取全文
Article -
14
Effect of intermittent subchronic MK‐801 administration on dopamine synthesis capacity and responsiveness in the prefrontal cortex 由 Kazuro Shibata, Kosuke Enomoto, Takahiro Tsutsumi, Hiroyuki Muraoka, Tatsu Fuwa, Masahiko Kawano, Jun Ishigooka, Ken Inada, Katsuji Nishimura, Hidehiro Oshibuchi
發表在 Neuropsychopharmacology Reports (2024-06-01)獲取全文
Article -
15
Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study 由 Yoshitaka Saito, Kyohei Sumida, Hiroyuki Muraoka, Satoru Oishi, Ryutaro Suzuki, Taiyo Nishikawa, Shin Miyake, Yukihiro Tanno, Yuki Tobita, Katsuya Otori, Ken Inada
發表在 BMC Psychiatry (2025-01-01)獲取全文
Article -
16
The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates 由 Hitoshi Isohata, Sumie Miura, Yu Yamazaki, Hiroyuki Goto, Yoshihiro Yoshimura, Kyoko Hattori, Takao Shimaoka, Kazuki Sekiguchi, Hidehiko Nakanishi, Ken Inada, Daigo Ochiai
發表在 Scientific Reports (2025-08-01)獲取全文
Article -
17
Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic 由 Yumi Aoki, Yumi Aoki, Yoshikazu Takaesu, Yoshikazu Takaesu, Ken Inada, Hiroki Yamada, Tomohiko Murao, Toshiaki Kikuchi, Masahiro Takeshima, Masayuki Tani, Kazuo Mishima, Tempei Otsubo
發表在 Frontiers in Psychiatry (2023-05-01)獲取全文
Article -
18
Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia 由 Yumi Aoki, Yoshikazu Takaesu, Kentaro Matsui, Takahiro Tokumasu, Hideaki Tani, Yoshiteru Takekita, Tetsufumi Kanazawa, Taishiro Kishimoto, Seiichiro Tarutani, Naoki Hashimoto, Hiroyoshi Takeuchi, Kazuo Mishima, Ken Inada
發表在 Neuropsychopharmacology Reports (2023-09-01)獲取全文
Article -
19
Development, reliability, and validity of the quality of life scale for insomnia: a health-related quality of life instrument for insomnia 由 Naoko Ayabe, Naoko Ayabe, Isa Okajima, Isa Okajima, Wataru Yamadera, Hisateru Tachimori, Hisateru Tachimori, Hidehisa Yamashita, Naohisa Uchimura, Ken Inada, Yuichi Inoue, Kazuo Mishima, Kazuo Mishima
發表在 Frontiers in Psychiatry (2025-05-01)獲取全文
Article -
20
Management of unspecified anxiety disorder: Expert consensus 由 Hitoshi Sakurai, Ken Inada, Yumi Aoki, Masahiro Takeshima, Kenya Ie, Morito Kise, Eriko Yoshida, Takashi Tsuboi, Hisashi Yamada, Hikaru Hori, Yasushi Inada, Eiji Shimizu, Kazuo Mishima, Koichiro Watanabe, Yoshikazu Takaesu
發表在 Neuropsychopharmacology Reports (2023-06-01)獲取全文
Article
